Ashish Ranjan
The first COVID-19 intranasal vaccination, iNCOVACC, was introduced today by Ministers of Science and Technology Jitendra Singh and Union Health Minister Dr. Mansukh Mandaviya. The vaccine, created by Indian company Bharat Biotech, will cost the government 325 per dosage while private hospitals will have to pay 800.
The primary 2-dose schedule and the heterologous booster dose were approved for the company in December 2022. Prior to that, the Central Drugs Standard Control Organization (CDSCO) had authorised the intranasal vaccine’s limited usage in emergency cases for people 18 years of age and older.
The vaccination must be administered in two doses separated by 28 days.
As per the head of the nation’s vaccine task force told last month, a week after the nasal vaccine was introduced on the CoWin platform, that people who have already received a precautionary or booster dose cannot receive the nasal vaccine.
Visit the CoWin website to schedule an appointment for the intranasal vaccine dose, according to the vaccine manufacturer Bharat Biotech.
In collaboration with Washington University in St. Louis, which created the recombinant adenoviral vectored construct and tested its efficacy in preclinical studies, iNCOVACC was created.
Bharat Biotech developed products involving preclinical safety assessment, large-scale manufacturing scale up, formulation and delivery device development, as well as human clinical trials.
Also Read:- Covid booster dose has best immune response
The Department of Biotechnology of the Government of India provided funding for product development and clinical trials under the Covid Suraksha programme.
How to register?
According to the intranasal vaccine manufacturer Bharat Biotech, you can schedule an appointment on the CoWin website. You must sign in using the one-time password (OTP) that was provided to your registered mobile number. The next step is to choose a slot.
